Alpha 2.0
Login Register
» Authors » Stephen DeWilde

Stephen DeWilde

Explore the profile of Stephen DeWilde including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 1170
Followers 0
Related Specialties
Public Health
General Medicine
Geriatrics
Top 10 Co-Authors
Derek G Cook
Tess Harris
Iain M Carey
Sunil M Shah
Christina R Victor
Carole Beighton
Umar A R Chaudhry
Julia A Critchley
Peter H Whincup
Fay J Hosking
Published In
Br J Gen Pract
Age Ageing
PLoS One
Diabetes Care
Br J Clin Pharmacol
Affiliations
Soon will be listed here.
Recent Articles
1.
Contribution of infection to mortality in people with type 2 diabetes: a population-based cohort study using electronic records
Carey I, Critchley J, Chaudhry U, DeWilde S, Limb E, Bowen L, et al.
Lancet Reg Health Eur . 2024 Dec; 48:101147. PMID: 39670170
Background: While people with type 2 diabetes (T2D) are more susceptible to infections, studies potentially underestimate the true burden of infection-related mortality since they rely on clinical coding systems primarily...
2.
Tuberculosis and Increased Incidence of Cardiovascular Disease: Cohort Study Using United States and United Kingdom Health Records
Critchley J, Limb E, Khakharia A, Carey I, Auld S, De Wilde S, et al.
Clin Infect Dis . 2024 Nov; 80(2):271-279. PMID: 39495677
Background: Limited evidence suggests elevated risks of cardiovascular disease (CVD) among people diagnosed with tuberculosis (TB) disease, though studies have not adjusted for preexisting CVD risk. We carried out a...
3.
Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data
Carey I, Critchley J, Chaudhry U, Cook D, DeWilde S, Limb E, et al.
Diabetes Res Clin Pract . 2024 Mar; 211:111641. PMID: 38548108
Aims: Long-term HbA1c (glycated haemoglobin) variability is associated with micro- and macrovascular complications in Type 2 diabetes (T2D). We explored prospective associations between HbA1c variability and serious infections, and how...
4.
A matched cohort study evaluating the risks of infections in people with type 1 diabetes and their associations with glycated haemoglobin
Chaudhry U, Carey I, Critchley J, DeWilde S, Limb E, Bowen L, et al.
Diabetes Res Clin Pract . 2023 Nov; 207:111023. PMID: 37984487
Aims: People with type 1 diabetes (T1D) have raised infection rates compared to those without, but how these risks vary by age, sex and ethnicity, or by glycated haemoglobin (HbA1c),...
5.
Evaluating Ethnic Variations in the Risk of Infections in People With Prediabetes and Type 2 Diabetes: A Matched Cohort Study
Carey I, Critchley J, Chaudhry U, DeWilde S, Limb E, Cook D, et al.
Diabetes Care . 2023 Apr; 46(6):1209-1217. PMID: 37043827
Objective: People living with type 2 diabetes (T2D) are at higher infection risk, but it is unknown how this risk varies by ethnicity or whether the risk is similarly observed...
6.
Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data
Carey I, Nirmalananthan N, Harris T, DeWilde S, Chaudhry U, Limb E, et al.
PLoS One . 2023 Mar; 18(3):e0282513. PMID: 36857388
Background: People with neuromuscular disease (NMD) experience a broader range of chronic diseases and health symptoms compared to the general population. However, no comprehensive analysis has directly quantified this to...
7.
Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data
Carey I, Banchoff E, Nirmalananthan N, Harris T, DeWilde S, Chaudhry U, et al.
PLoS One . 2021 Dec; 16(12):e0261983. PMID: 34972157
Background: In the UK, large-scale electronic primary care datasets can provide up-to-date, accurate epidemiological information on rarer diseases, where specialist diagnoses from hospital discharges and clinic letters are generally well...
8.
Risk factors for excess all-cause mortality during the first wave of the COVID-19 pandemic in England: A retrospective cohort study of primary care data
Carey I, Cook D, Harris T, DeWilde S, Chaudhry U, Strachan D
PLoS One . 2021 Dec; 16(12):e0260381. PMID: 34882700
Background: The COVID-19 pandemic's first wave in England during spring 2020 resulted in an approximate 50% increase in all-cause mortality. Previously, risk factors such as age and ethnicity, were identified...
9.
The rising tide of dementia deaths: triangulation of data from three routine data sources using the Clinical Practice Research Datalink
Ahmad S, Carey I, Harris T, Cook D, DeWilde S, Strachan D
BMC Geriatr . 2021 Jun; 21(1):375. PMID: 34154546
Background: Dementia is currently the leading certified underlying cause of death in England. We assess how dementia recording on Office for National Statistics death certificates (ONS) corresponded to recording in...
10.
Development of a structured clinical pharmacology review for specialist support for management of complex polypharmacy in primary care
Threapleton C, Kimpton J, Carey I, DeWilde S, Cook D, Harris T, et al.
Br J Clin Pharmacol . 2020 Feb; 86(7):1326-1335. PMID: 32058606
Aims: Polypharmacy is widespread and associated with medication-related harms, including adverse drug reactions, medication errors and poor treatment adherence. General practitioners and pharmacists cite limited time and training to perform...